Sama Therapeutics
Priyal Sheth, MSc, currently serves as Chief Business Officer at Sama Therapeutics since March 2023 and has also held a mentoring role at MassBio since July 2020. Priyal Sheth previously worked as Senior Director of Business Development at Invicro from August 2021 to February 2023, and as Head of Business Development at 20/15 Visioneers from November 2019 until February 2023. At MetaCell Ltd., LLC, between February 2019 and April 2020, Priyal Sheth operated as EVP of Client Relations within a neuroscience software and data analytics consultancy. Earlier experiences include a role as Sales Operations Specialist and Salesforce Admin at Myriad Supply and consultancy work focused on profit center growth at Mahavir Corporation. Priyal Sheth holds a Master's degree in Neuroscience and Education from Columbia University and has an educational background in economics from UC San Diego, alongside training at The Lee Strasberg Theatre and Film Institute.
This person is not in any teams
Sama Therapeutics
1 followers
Sama Therapeutics is a precision neuropsychiatry AI/ML platform that synthesizes and validates predictive biomarkers grounded in neural, physiological, multi-omics, natural language, and behavioral phenotypes. The company's agile SaaS platform, iMAGiNE™, analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI trained on proprietary and open-science datasets. With an extraordinarily interdisciplinary team, Sama Therapeutics is advancing "software as medical device" for a range of indications, including cognitive, affective, interoceptive, and substance use disorders. We invite partners to join our mission unlocking brain health through integrative neurotechnology and proven “transprognostic” algorithms: https://brainclinics.com/tdbrain-challenge/ Please reach out to contact@sama.ac for more information and a live demo.